The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis
Open accessAbstract
AIMS: Visfatin is a novel adipokine whose plasma concentrations are altered in obesity and obesity-related disorders; these states are associated with an increased incidence of cardiovascular disease. We therefore investigated the effect of visfatin on vascular endothelial growth factor (VEGF) and matrix metalloproteinases (MMP-2, MMP-9) production and the potential signalling cascades. METHODS AND RESULTS: In human umbilical vein endothelial cells (HUVECs), visfatin significantly and dose-dependently up-regulated gene expression and protein production of VEGF and MMPs and down-regulated expression of tissue inhibitors of MMPs (TIMP-1 and TIMP-2). The gelatinolytic activity of MMPs (analysed by zymography) correlated with mRNA and western blot findings. Interestingly, visfatin significantly up-regulated VEGF receptor 2 expression. Inhibition of VEGFR2 and VEGF [by soluble FMS-like tyrosine kinase-1 (sFlt1)] down-regulated visfatin-induced MMP induction. Visfatin induced dose- and time-dependent proliferation and capillary-like tube formation. Importantly, visfatin was noted to have anti-apoptotic effects. In HUVECs, visfatin dose-dependently activated PI3K/Akt (phosphatidylinositol 3-kinase/Akt) and ERK(1/2) (extracellular signal-regulated kinase) pathways. The functional effects and MMP/VEGF induction were shown to be dependent on the MAPK/PI3K-Akt/VEGF signalling pathways. Inhibition of PI3K/Akt and ERK(1/2) pathways led to significant decrease of visfatin-induced MMP and VEGF production and activation, along with significant reduction in endothelial proliferation and capillary tube formation. CONCLUSION: Our data provide the first evidence of visfatin-induced endothelial VEGF and MMP production and activity. Further, we show for the first time the involvement of the MAPK and PI3K/Akt signalling pathways in mediating these actions, as well as endothelial cell proliferation. Collectively, our findings provide novel insights into visfatin-induced endothelial angiogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new mathematical model for relative quantification in real-time RT-PCR
Pfaffl, M. W. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.9.e45 · Cited by 34,610
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Jaffe, E. A., Nachman, R. L., Becker, C. G., & Minick, C. R. (1973) · Journal of Clinical Investigation · doi:10.1172/jci107470 · Cited by 6,856
The Biology of Vascular Endothelial Growth Factor
Ferrara, N., & Davis-Smyth, T. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.1.0287 · Cited by 4,330
Galis, Z. S., Sukhova, G. K., Lark, M. W., & Libby, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117619 · Cited by 2,539
Ferrara, N., & Henzel, W. J. (1989) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(89)92678-8 · Cited by 2,268
The Emerging Concept of Vascular Remodeling
Epstein, F. H., Gibbons, G. H., & Dzau, V. J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405193302008 · Cited by 1,575
Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor
Terman, B. I., Dougher-Vermazen, M., Carrion, M. E., Dimitrov, D., Armellino, D. C., Gospodarowicz, D., & Böhlen, P. (1992) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(92)90483-2 · Cited by 1,519
Cardiovascular Medicine at the Turn of the Millennium: Triumphs, Concerns, and Opportunities
Braunwald, E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199711063371906 · Cited by 1,424
Cloning and characterization of the cDNA encoding a novel human pre-B-cell colony-enhancing factor.
Samal, B., Sun, Y., Stearns, G., Xie, C., Suggs, S., & McNiece, I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.2.1431 · Cited by 1,019
Adipose tissue as an endocrine and paracrine organ
Mohamed-Ali, V, Pinkney, J., & Coppack, S. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800770 · Cited by 999
Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke · doi:10.1161/01.str.29.10.2189 · Cited by 861
Vascular endothelial growth factor enhances atherosclerotic plaque progression
Celletti, F. L., Waugh, J. M., Amabile, P. G., Brendolan, A., Hilfiker, P. R., & Dake, M. D. (2001) · Nature Medicine · doi:10.1038/86490 · Cited by 708
Chen, M.-P., Chung, F.-M., Chang, D.-M., Tsai, J. C.-R., Huang, H.-F., Shin, S.-J., & Lee, Y.-J. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1475 · Cited by 660
Galis, Z. S., Muszynski, M., Sukhova, G. K., Simon-Morrissey, E., Unemori, E. N., Lark, M. W., Amento, E., & Libby, P. (1994) · Circulation Research · doi:10.1161/01.res.75.1.181 · Cited by 646
Creemers, E. E. J. M., Cleutjens, J. P. M., Smits, J. F. M., & Daemen, M. J. A. P. (2001) · Circulation Research · doi:10.1161/hh1501.094396 · Cited by 598
Kai, H., Ikeda, H., Yasukawa, H., Kai, M., Seki, Y., Kuwahara, F., Ueno, T., Sugi, K., & Imaizumi, T. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00250-2 · Cited by 590
Bendeck, M. P., Zempo, N., Clowes, A. W., Galardy, R. E., & Reidy, M. A. (1994) · Circulation Research · doi:10.1161/01.res.75.3.539 · Cited by 584
Gospodarowicz, D., Abraham, J. A., & Schilling, J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.19.7311 · Cited by 559
Wang, W., Schulze, C. J., Suarez-Pinzon, W. L., Dyck, J. R. B., Sawicki, G., & Schulz, R. (2002) · Circulation · doi:10.1161/01.cir.0000028818.33488.7b · Cited by 484
Dahl, T. B., Yndestad, A., Skjelland, M., Øie, E., Dahl, A., Michelsen, A., Damås, J. K., Tunheim, S. H., Ueland, T., Smith, C., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.665893 · Cited by 465
Wang, H., & Keiser, J. A. (1998) · Circulation Research · doi:10.1161/01.res.83.8.832 · Cited by 427
SGalis, Z., MMuszynski, KSukhova, G., ESimon-Morrissey, NUnemori, E., WLark, M., EAmento, & PLibby (1994) · Circulation Research · Cited by 402
Akt1/protein kinase B is critical for ischemic and VEGF-mediated angiogenesis
Ackah, E. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24726 · Cited by 385
Pre–B-Cell Colony-enhancing Factor as a Potential Novel Biomarker in Acute Lung Injury
Ye, S. Q., Simon, B. A., Maloney, J. P., Zambelli-Weiner, A., Gao, L., Grant, A., Easley, R. B., McVerry, B. J., Tuder, R. M., Standiford, T., et al. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-563oc · Cited by 376
Matrix Metalloproteinases in Cerebrovascular Disease
Mun-Bryce, S., & Rosenberg, G. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00001 · Cited by 348
Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
Duh, E., & Aiello, L. P. (1999) · Diabetes · doi:10.2337/diabetes.48.10.1899 · Cited by 319
Haider, D. G., Schindler, K., Schaller, G., Prager, G., Wolzt, M., & Ludvik, B. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2248 · Cited by 303
The Regulation of Neovascularization by Matrix Metalloproteinases and Their Inhibitors
Moses, M. A. (1997) · STEM CELLS · doi:10.1002/stem.150180 · Cited by 298
Olson, M. W., Gervasi, D. C., Mobashery, S., & Fridman, R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.47.29975 · Cited by 288
Resistin, Obesity, and Insulin Resistance — The Emerging Role of the Adipocyte as an Endocrine Organ
Shuldiner, A. R., Yang, R., & Gong, D.-W. (2001) · New England Journal of Medicine · doi:10.1056/nejm200111013451814 · Cited by 264
Godin, D., Ivan, E., Johnson, C., Magid, R., & Galis, Z. S. (2000) · Circulation · doi:10.1161/01.cir.102.23.2861 · Cited by 192
Lang, I., Pabst, M. A., Hiden, U., Blaschitz, A., Dohr, G., Hahn, T., & Desoye, G. (2003) · European Journal of Cell Biology · doi:10.1078/0171-9335-00306 · Cited by 186
Visfatin promotes angiogenesis by activation of extracellular signal-regulated kinase 1/2
Kim, S.-R., Bae, S., Choi, K., Park, S.-Y., Jun, H. O., Lee, J. Y., Jang, H., Yun, I., Yoon, K., Kim, Y.-J., et al. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.03.105 · Cited by 156
Akt1 in the cardiovascular system: friend or foe?
O'Neill, B. T. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25900 · Cited by 141
Insulin Action in the Vasculature: Physiology and Pathophysiology
Mather, K. J., Anderson, T. J., & Verma, S. (2001) · Journal of Vascular Research · doi:10.1159/000051074 · Cited by 123
Decreased Plsma Visfatin Concentrations in Women With Gestational Diabetes Mellitus
Chan, T., Chen, Y., Lee, C., Chou, F., Wu, L.-C., Jong, S., & Tsai, E. (2006) · Journal of the Society for Gynecologic Investigation · doi:10.1016/j.jsgi.2006.04.007 · Cited by 115
Tan, B. K., Chen, J., Digby, J. E., Keay, S. D., Kennedy, C. R., & Randeva, H. S. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0936 · Cited by 113
Self-citationHeterogeneity of Vascular Endothelial Cells in Normal and Disease States
Thorin, É. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00005-9 · Cited by 112
Endothelial cell apoptosis in capillary network remodeling
Pollman, M. J., Naumovski, L., & Gibbons, G. H. (1999) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(199903)178:3<359::aid-jcp10>3.0.co;2-o · Cited by 106
Plaque Disruption and Thrombosis: Potential Role of Inflammation and Infection
Shah, P. K. (2000) · Cardiology in Review · doi:10.1097/00045415-200008010-00007 · Cited by 77
Plaque disruption and thrombosis: potential role of inflammation and infection.
Shah, P. K. (2001) · PubMed · Cited by 69
Dye, J. F., Lawrence, L., Linge, C., Leach, L., Firth, J. A., & Clark, P. (2004) · Endothelium · doi:10.1080/10623320490512093 · Cited by 67
Paracrine interactions in adipose tissue development and growth.
Dc, L., Schillabeer, G., Zh, L., et al. (1996) · PubMed · Cited by 48
Boguslawski, G., McGlynn, P. W., Harvey, K. A., & Kovala, A. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m308625200 · Cited by 37
Liu, Y., Mustafa, M., Li, H., Nuortio, L., Mustafa, A., & Bakhiet, M. (2000) · NeuroImmunoModulation · doi:10.1159/000026450 · Cited by 33
Cited by
Physiological and pathophysiological roles of NAMPT and NAD metabolism.
Garten, A., Schuster, S., Penke, M., Gorski, T., de Giorgis, T., & Kiess, W. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.117 · Cited by 708
Obesity and asthma: Possible mechanisms
Shore, S. A. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.03.004 · Cited by 453
Nampt: linking NAD biology, metabolism and cancer
Garten, A., Petzold, S., Körner, A., Imai, S.-I., & Kiess, W. (2009) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2008.10.004 · Cited by 398
Kaur, J., Adya, R., Tan, B. K., Chen, J., & Randeva, H. S. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.150 · Cited by 349
Self-citationWang, P., Xu, T.-Y., Guan, Y.-F., Su, D.-F., Fan, G.-R., & Miao, C.-Y. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvn288 · Cited by 304
Metadata
- Authors
- Adya, R., Tan, B. K., Punn, A., Chen, J., & Randeva, H. S.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-12-18
- Volume
- 78
- Issue
- 2
- Pages
- 356-365
- ISSN
- 0008-6363 (ISSN-L)
- 1755-3245
- OpenAlex
- W2025750169
- Cited by
- 437
- References
- 46
- FWCI
- 5.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.